Skip to main content
. 2013 Oct;4(2):105–115. doi: 10.1055/s-0033-1357361

Table 2. Studies comparing the use of miniplates with no plates for cervical laminoplasty: characteristics of included studies.

Investigator
(y)
Study design
CoE
Demographicsa Diagnosis Laminoplasty with miniplates Laminoplasty with no plates Follow-up
(% followed up)
Reported outcomes Post-op care (collar, orthosis, and mobilization)
Wang et al9
RCT
CoE: II
  • N = 49

  • Age (mean): 60.0 y (36–76)

  • Male: 63%

  • CSM (n = 28), OPLL (n = 9), or CDH (n = 12)

  • Symptom duration (mean): NR

  • Open door with titanium miniplates (n = 25)

  • Treated levels: C3–C7

  • Number of plates used: five per patient

  • Open door with sutures (n = 24)

  • Treated levels: C3–C7

21.2 ± 2.1 mo (98)
  • Complications

  • JOA

  • axial pain (VAS)

  • SF-36

  • C2–C7 angle

  • Patients with plates: collar worn for 2 weeks, then gradual mobilization in flexion-extension, rotation, and side bending

  • Patients with no plates: collar worn for 6 weeks, then gradual mobilization

Jiang et al10
Retrospective cohort
CoE: III
  • N = 61

  • Age (mean): 58 y (41–81)

  • Male: 66%

  • CSM with multilevel spinal stenosis (n = 34) or OPLL (n = 27)

  • Symptom duration (mean): NR

  • Open door with titanium miniplates (n = 38)

  • Treated levels: C3–C7

  • Number of plates used (number of patients): 2 plates (n = 6), 3 plates (n = 27), 4 plates (n = 3), and 5 plates (n = 2)

  • Open door with sutures (n = 21)

  • Treated levels: C3–C7

20 months (13–39) (80.3)
  • JOA

  • Spinal canal expansion

  • Axial symptoms

  • Cervical spine ROM

  • Complications, including hardware failure

  • Patients allowed to sit up or walk between 3 and 5 days postoperative

  • Cervical brace worn for 3 months

Abbreviations: CDH, cervical disc herniation; CoE, class of evidence; CSM, cervical spondylotic myelopathy; JOA, Japanese Orthopedic Association score; NR, not reported; OPLL, ossification of posterior longitudinal ligament; RCT, randomized controlled trial; SF-36, short form 36 health survey questionnaire; VAS, visual analog scale.

a

Demographics reflect the number of patients after loss to follow-up (n = 49).9